<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02943681</url>
  </required_header>
  <id_info>
    <org_study_id>MV18Months</org_study_id>
    <nct_id>NCT02943681</nct_id>
  </id_info>
  <brief_title>A Second Dose of Measles Vaccine (MV) in the Second Year of Life</brief_title>
  <official_title>Boosting the Beneficial Non-specific Effects of Live Attenuated Vaccines: A Randomized Controlled Trial (RCT) of a Second Dose of Measles Vaccine (MV) in the Second Year of Life</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bandim Health Project</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bandim Health Project</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the non-specific effects on child mortality and morbidity of a second
      dose of measles in the second year of life. Half of the study participants will receive a
      second dose of measles vaccine at 18 months of age while the other half will receive a second
      dose of measles by 4 years of age or at the end of the study.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">July 2021</completion_date>
  <primary_completion_date type="Anticipated">July 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>30 months</time_frame>
    <description>Mortality registered monthly by Health and Demographic Surveillance System fieldworkers. Mortality will be combined with hospital admissions in the analysis to form the outcome severe morbidity. This will be examined overall and by sex</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hospital admissions</measure>
    <time_frame>30 months</time_frame>
    <description>Hospital admissions registered daily at the national hospital. Hospital admissions will be combined with mortality in the analysis to form the outcome severe morbidity. This will be examined overall and by sex</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hospital admission by cause</measure>
    <time_frame>30 months</time_frame>
    <description>Causes of hospital admissions registered daily at the national hospital. These will be examined overall and by sex</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Consultations</measure>
    <time_frame>30 months</time_frame>
    <description>Consultations registered daily at the local health centers and the national hospital. These will be examined overall and by sex</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">8500</enrollment>
  <condition>Child Mortality</condition>
  <condition>Child Morbidity</condition>
  <arm_group>
    <arm_group_label>Measles vaccine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Measles vaccine, 1 dose of 0.5 ml</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Nothing</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Measles vaccine</intervention_name>
    <arm_group_label>Measles vaccine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children need to have received the third dose of inactivated vaccines (Penta, PCV13
             and IPV) before measles vaccination.

        Exclusion Criteria:

          -  Having severe malformations that impairs their health

          -  Having received a second dose of measles vaccine

          -  Severely ill (requiring hospitalization) upon clinical examination
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Months</minimum_age>
    <maximum_age>24 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Bandim Health Project, Apartado 861</name>
      <address>
        <city>Bissau</city>
        <country>Guinea-Bissau</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Aaby</last_name>
      <phone>0045 3268 3268</phone>
      <email>p.aaby@bandim.org</email>
    </contact>
    <contact_backup>
      <last_name>Amabelia Rodrigues</last_name>
      <email>a.rodrigues@bandim.org</email>
    </contact_backup>
    <investigator>
      <last_name>Peter Aaby</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Guinea-Bissau</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 13, 2016</study_first_submitted>
  <study_first_submitted_qc>October 21, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 25, 2016</study_first_posted>
  <last_update_submitted>October 27, 2016</last_update_submitted>
  <last_update_submitted_qc>October 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

